DOCPHARMA
ActiveSummary
DOCPHARMA has been active since 1999 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €36.55M and a net result of €581k. Equity remains stable across the filed fiscal years (±1.4% per year). The computed 12-month bankruptcy probability is 0.5% (low).
Checked score
Score 2025
80
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability41▼-3
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
0.5%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €2M at 30 days acceptable
short-term debt: 0% of total assets, and 24.2% of the assets are financed with debt.
Credit check for your own amount and term
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
75.8%
Return on assets
1.2%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 07-07-2026, 24 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
24 d early
2024
34 d early
2023
34 d early
2022
20 d early
2021
24 d early
2020
18 d early
2019
22 d early
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, full schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€581k▼ 51.8%
2024 · €1.21M
2018: €-457k
2019: €-460k
2020: €-414k
2022: €1.24M
2023: €789k
2024: €1.21M
2018 → 2025
Working capital
€48.19M▲ 2.2%
2024 · €47.16M
2018: €47.80M
2019: €47.77M
2020: €47.81M
2022: €44.26M
2023: €45.50M
2024: €47.16M
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202022202320242025Trend
Equity€33.21M-€33.97M▲ 2.3%€34.76M▲ 2.3%€35.97M▲ 3.5%€36.55M▲ 1.6%
Operating result€-421k-€-433k▼ 2.9%€-465k▼ 7.2%€-469k▼ 1.0%€-477k▼ 1.6%
Net result€-414k-€1.24M€789k▼ 36.2%€1.21M▲ 53.0%€581k▼ 51.8%
Result per fiscal year
Operating resultNet result
The operating result stays negative: a loss of €477k in 2025 against €469k in 2024; the loss grows and 2025 has the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Equity and liabilities €48.20M
Equity
€36.55M ▲ 1.6%
Provisions
€11.64M ▲ 4.0%
Debt
€14k ▲ 9.8%
Debt's share of the balance-sheet total stays at 0.0%.
Key figures and ratios
Debt to equity
0.00▲
2024 · 0.00
ROE
1.6%▼
2024 · 3.4%
ROA
1.2%▼
2024 · 2.6%
Debt ≤ 1 year
€14k▲
2024 · €12k
A ratio outside any meaningful range has been withheld (balance sheet total €48.20M, equity €36.55M).
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 41 lines
Balance sheet
Code20242025
Assets
Total assets20/58€47.17M€48.20M▲
Formation expenses20€0€0=
Fixed assets21/28€0€0=
Tangible fixed assets22/27€0€0=
Furniture and vehicles24€0€0=
Financial fixed assets28€0€0=
Affiliated companies280/1€0€0=
Participating interests280€0€0=
Current assets29/58€47.17M€48.20M▲
Amounts receivable within one year40/41€47.17M€48.20M▲
Other amounts receivable41€47.17M€48.20M▲
Equity and liabilities
Total equity and liabilities10/49€47.17M€48.20M▲
Equity10/15€35.97M€36.55M▲
Contributions10/11€83.29M€83.29M=
Profit (loss) carried forward14€-47.32M€-46.74M▲
Provisions and deferred taxes16€11.19M€11.64M▲
Provisions for liabilities and charges160/5€11.19M€11.64M▲
Other liabilities and charges164/5€11.19M€11.64M▲
Amounts payable17/49€12k€14k▲
Amounts payable within one year42/48€12k€14k▲
Trade debts44€12k€14k▲
Suppliers440/4€12k€14k▲
Other amounts payable47/48€0€0=
Income statement
Code20242025
Operating charges60/66A€469k€477k▲
Services and other goods61€16k€25k▲
Provisions for liabilities and charges: additions (uses and reversals)635/8€453k€452k▼
Operating profit (loss)9901€-469k€-477k▼
Financial income75/76B€1.70M€1.06M▼
Recurring financial income75€1.70M€1.06M▼
Income from current assets751€1.70M€1.06M▼
Other financial income752/9€0€0=
Financial charges65/66B€2k€764▼
Recurring financial charges65€2k€764▼
Other financial charges652/9€2k€764▼
Profit (loss) for the period before taxes9903€1.23M€581k▼
Income taxes67/77€20k-
Taxes670/3€20k-
Profit (loss) for the period9904€1.21M€581k▼
Profit (loss) for the period to be appropriated9905€1.21M€581k▼
Appropriation of the result
Profit (loss) to be appropriated9906€-47.32M€-46.74M▲
Profit (loss) brought forward from the previous period14P€-48.53M€-47.32M▲
The notes to these accounts (24 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
07-07
NBB filing
Annual accounts filed
fiscal year 2025 · full schema
02-07
State Gazette act
Reappointment: Deloitte Bedrijfsrevisoren BV (statutory auditor)Power of attorney · Auditor mandate expiration5 facts ▸
State Gazette act
Reappointment: Deloitte Bedrijfsrevisoren BV (statutory auditor)
Power of attorney · Auditor mandate expiration5 facts ▸
- General meeting, 18-06-2026
- Auditor reappointment, Deloitte Bedrijfsrevisoren BV (statutory auditor)
- Power of attorney, Johan Lagae
- Power of attorney, Els Bruls
- Auditor mandate expiration, commissaris, at this OGM
2025
10-12
State Gazette act
Resignation: Matthew Salzmann (director)Appointment: Arun Narayan (director) · Mandate compensation · Power of attorney6 facts ▸
State Gazette act
Resignation: Matthew Salzmann (director)
Appointment: Arun Narayan (director) · Mandate compensation · Power of attorney6 facts ▸
- Shareholder decision, 25-11-2025
- Director resignation, Matthew Salzmann (director)
- Director appointment, Arun Narayan (director)
- Mandate compensation, Arun Narayan
- Power of attorney, Johan Lagae
- Power of attorney, Els Bruls
10-07
State Gazette act
Resignation: Vincent Verschraegen (director)Appointment: Tomasz Buczek (director) · Mandate compensation · Power of attorney6 facts ▸
State Gazette act
Resignation: Vincent Verschraegen (director)
Appointment: Tomasz Buczek (director) · Mandate compensation · Power of attorney6 facts ▸
- Shareholder decision, 24-06-2025
- Director resignation, Vincent Verschraegen (director)
- Director appointment, Tomasz Buczek (director)
- Mandate compensation, Tomasz Buczek
- Power of attorney, Johan Lagae
- Power of attorney, Els Bruls
27-06
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
2024
31-12
Financial
Liquidity doublescurrent ratio 3784.05
Current ratio from 1643.12 to 3784.05; short-term debt falls from €28k to €12k.
27-06
NBB filing
Annual accounts filed
fiscal year 2023 · full schema
21-03
State Gazette act
Resignation: Luis Birbuet (director)Appointment: Matthew Salzmann (director) · Mandate compensation · Power of attorney6 facts ▸
State Gazette act
Resignation: Luis Birbuet (director)
Appointment: Matthew Salzmann (director) · Mandate compensation · Power of attorney6 facts ▸
- General meeting, 28-02-2024
- Director resignation, Luis Birbuet (director)
- Director appointment, Matthew Salzmann (director)
- Mandate compensation, Matthew Salzmann
- Power of attorney, Johan Lagae
- Power of attorney, Els Bruls
2023
11-07
State Gazette act
Reappointment: Deloitte Bedrijfsrevisoren BV (statutory auditor)Power of attorney4 facts ▸
State Gazette act
Reappointment: Deloitte Bedrijfsrevisoren BV (statutory auditor)
Power of attorney4 facts ▸
- General meeting, 28-06-2023
- Auditor reappointment, Deloitte Bedrijfsrevisoren BV (statutory auditor)
- Power of attorney, Johan Lagae
- Power of attorney, Els Bruls
11-07
NBB filing
Annual accounts filed
fiscal year 2022 · full schema
2022
31-12
Financial
Back to profitnet €1.24M
Net result €1.24M after 3 loss-making years.
07-07
NBB filing
Annual accounts filed
fiscal year 2021 · full schema
Show earlier events
2021
13-07
NBB filing
Annual accounts filed
fiscal year 2020 · full schema
14-04
State Gazette act
Resignation: José Cotarelo (director)Appointment: Luis Birbuet (director) · Mandate compensation6 facts ▸
State Gazette act
Resignation: José Cotarelo (director)
Appointment: Luis Birbuet (director) · Mandate compensation6 facts ▸
- General meeting, 30-03-2021
- Director resignation, José Cotarelo (director)
- Director appointment, Luis Birbuet (director)
- Mandate compensation, Luis Birbuet
- Board composition, Vincent Verschraegen (director)
- Board composition, Luis Birbuet (director)
2020
31-12
Financial
Liquidity times 6current ratio 20546.75
Current ratio from 3553.83 to 20546.75; short-term debt falls from €13k to €2k.
14-07
State Gazette act
Reappointment: Deloitte Bedrijfsrevisoren (statutory auditor)Power of attorney3 facts ▸
State Gazette act
Reappointment: Deloitte Bedrijfsrevisoren (statutory auditor)
Power of attorney3 facts ▸
- General meeting, 18-06-2020
- Auditor reappointment, Deloitte Bedrijfsrevisoren
- Power of attorney, Joanna Bochner
09-07
NBB filing
Annual accounts filed
fiscal year 2019 · full schema
2019
31-12
Financial
Weakest financial yearnet €-460k
Net result drops to €-460k, the lowest in the series; recovery starts the following year.
09-07
NBB filing
Annual accounts filed
fiscal year 2018 · full schema
08-02
State Gazette act
Resignations: Anthonius van 't Hullenaar (manager) and Maximilian von Wülfing (manager)Appointments: Vincent Verschraegen (manager) and Jose Cotarelo (manager) · Permanent representative: Vincent Verschraegen · Mandate compensation9 facts ▸
State Gazette act
Resignations: Anthonius van 't Hullenaar (manager) and Maximilian von Wülfing (manager)
Appointments: Vincent Verschraegen (manager) and Jose Cotarelo (manager) · Permanent representative: Vincent Verschraegen · Mandate compensation9 facts ▸
- General meeting, 20-12-2018
- Director resignation, Anthonius van 't Hullenaar (manager)
- Director resignation, Maximilian von Wülfing (manager)
- Director appointment, Vincent Verschraegen (manager)
- Director appointment, Jose Cotarelo (manager)
- Mandate compensation, Vincent Verschraegen
- Mandate compensation, Jose Cotarelo
- Board meeting, 20-12-2018
- Permanent representative, Vincent Verschraegen
2018
04-07
NBB filing
Annual accounts filed
fiscal year 2017 · full schema
2017
05-10
State Gazette act
Reappointment: Deloitte Bedrijfsrevisoren (statutory auditor)2 facts ▸
State Gazette act
Reappointment: Deloitte Bedrijfsrevisoren (statutory auditor)
2 facts ▸
- General meeting, 30-08-2017
- Auditor reappointment, Deloitte Bedrijfsrevisoren
13-09
NBB filing
Annual accounts filed
fiscal year 2016 · full schema · 44 days late
05-05
State Gazette act
Resignation: Jens Neuschaefer (manager)Appointments: Anthonius van 't Hullenaar (manager) and Maximilian von Wülfing (manager) · Permanent representative: Anthonius van 't Hullenaar · Mandate compensation8 facts ▸
State Gazette act
Resignation: Jens Neuschaefer (manager)
Appointments: Anthonius van 't Hullenaar (manager) and Maximilian von Wülfing (manager) · Permanent representative: Anthonius van 't Hullenaar · Mandate compensation8 facts ▸
- General meeting, 15-03-2017
- Director resignation, Jens Neuschaefer (manager)
- Director appointment, Anthonius van 't Hullenaar (manager)
- Director appointment, Maximilian von Wülfing (manager)
- Mandate compensation, Anthonius van 't Hullenaar
- Mandate compensation, Maximilian von Wülfing
- Board meeting, 15-03-2017
- Permanent representative, Anthonius van 't Hullenaar
24-01
State Gazette act
Resignation: Yves Brigode (manager)3 facts ▸
State Gazette act
Resignation: Yves Brigode (manager)
3 facts ▸
- General meeting, 05-01-2017
- Director resignation, Yves Brigode (manager)
- Board composition, Jens Neuschaefer (manager)
2016
15-09
State Gazette act
Appointment: Jens Neuschaefer (manager)Mandate compensation3 facts ▸
State Gazette act
Appointment: Jens Neuschaefer (manager)
Mandate compensation3 facts ▸
- General meeting, 08-08-2016
- Director appointment, Jens Neuschaefer (manager)
- Mandate compensation, Jens Neuschaefer
2015
09-09
State Gazette act
Resignation: Khadija Badli (manager)Appointment: Yves Brigode (manager) · Mandate compensation · Power of attorney6 facts ▸
State Gazette act
Resignation: Khadija Badli (manager)
Appointment: Yves Brigode (manager) · Mandate compensation · Power of attorney6 facts ▸
- General meeting, 20-08-2015
- Director resignation, Khadija Badli (manager)
- Director appointment, Yves Brigode (manager)
- Mandate compensation, Yves Brigode
- Power of attorney, Yves Brigode
- Power of attorney, Karen Laevaert
28-01
State Gazette act
Resignation: Gary Sphar (manager)Power of attorney3 facts ▸
State Gazette act
Resignation: Gary Sphar (manager)
Power of attorney3 facts ▸
- General meeting, 30-12-2014
- Director resignation, Gary Sphar (manager)
- Power of attorney, Karen Laevaert
2014
23-07
State Gazette act
Reappointment: Deloitte Bedrijfsrevisoren (statutory auditor)Power of attorney3 facts ▸
State Gazette act
Reappointment: Deloitte Bedrijfsrevisoren (statutory auditor)
Power of attorney3 facts ▸
- General meeting, 19-06-2014
- Auditor reappointment, Deloitte Bedrijfsrevisoren
- Power of attorney, Karen Laevaert
2013
30-12
State Gazette act
Resignation: Mylan BVBA (manager)Appointment: Khadija Badli (manager) · Mandate compensation4 facts ▸
State Gazette act
Resignation: Mylan BVBA (manager)
Appointment: Khadija Badli (manager) · Mandate compensation4 facts ▸
- General meeting, 11-12-2013
- Director resignation, Mylan BVBA (manager)
- Director appointment, Khadija Badli (manager)
- Mandate compensation, Khadija Badli
02-10
State Gazette act
Resignation: Pascale Engelen (manager)Appointment: Mylan BVBA (manager) · Mandate compensation4 facts ▸
State Gazette act
Resignation: Pascale Engelen (manager)
Appointment: Mylan BVBA (manager) · Mandate compensation4 facts ▸
- General meeting, 28-08-2013
- Director resignation, Pascale Engelen (manager)
- Director appointment, Mylan BVBA (manager)
- Mandate compensation, Mylan BVBA
10-01
State Gazette act
Resignation: Didier Barret (manager)Appointment: Gary Sphar (manager) · Mandate compensation4 facts ▸
State Gazette act
Resignation: Didier Barret (manager)
Appointment: Gary Sphar (manager) · Mandate compensation4 facts ▸
- General meeting, 20-12-2012
- Director resignation, Didier Barret (manager)
- Director appointment, Gary Sphar (manager)
- Mandate compensation, Gary Sphar
2012
01-02
State Gazette act
Reappointment: Deloitte Bedrijfsrevisoren (statutory auditor)3 facts ▸
State Gazette act
Reappointment: Deloitte Bedrijfsrevisoren (statutory auditor)
3 facts ▸
- Board meeting, 09-01-2012
- General meeting, 11-01-2012
- Auditor reappointment, Deloitte Bedrijfsrevisoren
2011
07-04
State Gazette act
Resignation: Heather Bresch (manager)2 facts ▸
State Gazette act
Resignation: Heather Bresch (manager)
2 facts ▸
- General meeting, 17-03-2011
- Director resignation, Heather Bresch (manager)
16-03
State Gazette act
Resignations: Seshan Srinivasan, Malik Rajiv and Bouldoires VincentAppointment: Pascale Engelen (manager) · Mandate compensation6 facts ▸
State Gazette act
Resignations: Seshan Srinivasan, Malik Rajiv and Bouldoires Vincent
Appointment: Pascale Engelen (manager) · Mandate compensation6 facts ▸
- General meeting, 21-02-2011
- Director resignation, Seshan Srinivasan (manager)
- Director resignation, Malik Rajiv (manager)
- Director resignation, Bouldoires Vincent (manager)
- Director appointment, Pascale Engelen (manager)
- Mandate compensation, Pascale Engelen
2010
20-10
State Gazette act
Permanent representative: V. BouldoiresResignation: Prasad Nimmagadda (director) · Power of attorney6 facts ▸
State Gazette act
Permanent representative: V. Bouldoires
Resignation: Prasad Nimmagadda (director) · Power of attorney6 facts ▸
- Board meeting, 20-05-2010
- Permanent representative, V. Bouldoires
- Director resignation, Prasad Nimmagadda (director)
- General meeting, 17-06-2010
- Director resignation, Prasad Nimmagadda (manager)
- Power of attorney, Karen Laevaert
25-02
State Gazette act
Appointments: Bouldoires Vincent Pierre, Bresch Heather Mangrin and 4 othersResignation: Docpharma (director) · Legal-form conversion · Capital11 facts ▸
State Gazette act
Appointments: Bouldoires Vincent Pierre, Bresch Heather Mangrin and 4 others
Resignation: Docpharma (director) · Legal-form conversion · Capital11 facts ▸
- General meeting, 27-01-2010
- Legal-form conversion, naamloze vennootschap -> besloten vennootschap met beperkte aansprakelijkheid
- Capital, €57.578.062,74
- Director appointment, Bouldoires Vincent Pierre (manager)
- Director appointment, Bresch Heather Mangrin (manager)
- Director appointment, Barret Didier Henri (manager)
- Director appointment, Seshan Srinivasan (manager)
- Director appointment, Nimmagadda Prasad (manager)
- Director appointment, Malik Rajiv (manager)
- Mandate compensation, Bouldoires Vincent Pierre
- Director resignation, Docpharma
20-01
State Gazette act
Statutes amendmentAccounting effect4 facts ▸
State Gazette act
Statutes amendment
Accounting effect4 facts ▸
- General meeting, 28-12-2009
- Statutes amendment
- Statutes amendment
- Accounting effect, 01-04-2009
08-01
State Gazette act
Registered officeRegistered-office move2 facts ▸
State Gazette act
Registered office
Registered-office move2 facts ▸
- Board meeting, 11-12-2009
- Registered-office move, Terhulpsesteenweg 6A, 1560 Hoeilaart
2009
10-08
State Gazette act
Appointment: Vincent Bouldoires (general manager)Reappointment: Deloitte Bedrijfsrevisoren (statutory auditor)4 facts ▸
State Gazette act
Appointment: Vincent Bouldoires (general manager)
Reappointment: Deloitte Bedrijfsrevisoren (statutory auditor)4 facts ▸
- Board meeting, 06-07-2009
- Director appointment, Vincent Bouldoires (general manager)
- General meeting, 20-07-2009
- Auditor reappointment, Deloitte Bedrijfsrevisoren
2007
26-02
State Gazette act
Resignations: C.S Murali, C Ramakrishna and Matrix Laboratories NVAppointments: Robert Coury, Edward Borkowski and Heather Bresch · Director discharge10 facts ▸
State Gazette act
Resignations: C.S Murali, C Ramakrishna and Matrix Laboratories NV
Appointments: Robert Coury, Edward Borkowski and Heather Bresch · Director discharge10 facts ▸
- General meeting, 08-02-2007
- Director resignation, C.S Murali (director)
- Director resignation, C Ramakrishna (director)
- Director resignation, Matrix Laboratories NV (director)
- Director discharge, C.S Murali
- Director discharge, C Ramakrishna
- Director discharge, Matrix Laboratories NV
- Director appointment, Robert Coury (director)
- Director appointment, Edward Borkowski (director)
- Director appointment, Heather Bresch (director)
2005
14-03
State Gazette act
Resignations: Etienne Lenoir (director) and Maarten Coolen (director)Appointment: Anthony Herbert Bloom (director) · Director discharge6 facts ▸
State Gazette act
Resignations: Etienne Lenoir (director) and Maarten Coolen (director)
Appointment: Anthony Herbert Bloom (director) · Director discharge6 facts ▸
- General meeting, 29-10-2004
- Director resignation, Etienne Lenoir (director)
- Director resignation, Maarten Coolen (director)
- Director discharge, Etienne Lenoir
- Director discharge, Maarten Coolen
- Director appointment, Anthony Herbert Bloom (director)
17-01
State Gazette act
Appointment: Van Rompay Management (afgevaardigd bestuurder)Permanent representative: Leon Van Rompay · Ratification4 facts ▸
State Gazette act
Appointment: Van Rompay Management (afgevaardigd bestuurder)
Permanent representative: Leon Van Rompay · Ratification4 facts ▸
- Board meeting, 21-12-2004
- Director appointment, Van Rompay Management (afgevaardigd bestuurder)
- Permanent representative, Leon Van Rompay
- Ratification, alle handelingen gesteld in de hoedanigheid van afgevaardigd bestuurder sinds 24 november 2003
2004
19-07
State Gazette act
Resignations & appointmentsStatutes amendment · Power of attorney4 facts ▸
State Gazette act
Resignations & appointments
Statutes amendment · Power of attorney4 facts ▸
- General meeting, 02-07-2004
- Statutes amendment
- Power of attorney, Leon Van Rompay
- Power of attorney, Stijn Van Rompay
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
9 directors, no change since 2025
Arun Narayan
CurrentDirector · since 26-11-2025
Tomasz Buczek
CurrentDirector · since 25-06-2025
Barret Didier Henri
Not recently confirmedManager · since 27-01-2010
Bouldoires Vincent Pierre
Not recently confirmedManager · since 27-01-2010
Bresch Heather Mangrin
Not recently confirmedManager · since 27-01-2010
Edward Borkowski
Not recently confirmedDirector · since 09-02-2007
3 other directors
Robert Coury
Not recently confirmedDirector · since 09-02-2007
Anthony Herbert Bloom
Not recently confirmedDirector · since 29-10-2004
Van Rompay Management
Not recently confirmedAfgevaardigd bestuurder · since 24-11-2003 · Legal entity · perm. rep.: Leon Van Rompay
26-11-2025
Arun Narayan: Appointed as Director
26-11-2025
Matthew Salzmann: Resigned as Director
01-07-2025
Vincent Verschraegen: Resigned as Director
25-06-2025
Tomasz Buczek: Appointed as Director
01-03-2024
Matthew Salzmann: Appointed as Director
Location & real-estate footprint
Registered office, Hoeilaart · 1 establishment unit since 1999
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Terhulpsesteenweg 61560 HoeilaartGround area
5,791 m²
Building footprint
1,094 m²
Volume, LiDAR
11,847 m³
2 parcels, Flanders · tallest building 15.2 m, ±4 floors. Linked by address, not a title deed.
1 establishment unit
Terhulpsesteenweg 6A, 1560 Hoeilaart
since 19992.103.154.988
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 23033C0075/00L019 | Flanders | 3,821 m² | 1 · 921 m² | 14.7 m · 4 fl. |
| 23033C0073/00E009 | Flanders | 1,970 m² | 1 · 173 m² | 15.2 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Statutory auditor
1 auditor| Deloitte Bedrijfsrevisoren/Réviseurs d’EntreprisesCurrent Statutory auditor · represented by Tom Renders | 26-09-2008 → present |
Articles of association
Purpose
Alle industrieie, commerciele verrichtingen met betrekking tot de chemische, farmaceutische, dieetvoeding- en cosmeticaproducten; alle industriële, commerciele verrichtingen met…
Full purpose
Alle industrieie, commerciele verrichtingen met betrekking tot de chemische, farmaceutische, dieetvoeding- en cosmeticaproducten; alle industriële, commerciele verrichtingen met betrekking tot producten die dienstig zijn in de medische sector; vertegenwoordiging en verkoop voor derden van alierlei materialen, toestellen en diensten, vertegenwoordiging, aan- en verkoop, im- en export, verhuur en instaliatie van medische apparatuur, pacemakers, medische en paramedische materialen en alle randapparatuur en toebehoren daarmee gepaard gaande, alsmede het onderhoud ervan; alle verrichtingen van commerciele, industritle, onroerende, roerende en financiele aard, die rechtstreeks met dit doel verwant of verknocht zijn, of de verwezenlijking ervan kunnen bevorderen; de vestiging en de uitbating van brevetten, merken, licenties en octrooien met betrekking tot de hierboven vermelde producten; de uitbating, de concessie, aankoop, verkoop en veruuwr van de lokalen of enroerende goederen waarin de bovenvermelde activiteiten kunnen worden gerealiscerd en alle toebehoren; belangenbehartiging t.a.v, prijzen en terugbetalingen t.o.v. diverse administraties en belangengroeperingen in de farnaceutische sector; de vennootschap mag haar doel verwezenlijken in Belgie zowel als in het buitenland, op alle wijzen en manieren die zij het best geschikt acht. Zij mag eveneens belangen verwerven bij wijze van inbreng, inschrijving of anderszins, in alle ondememingen of vennootschappen die een gelijkaardig analoog of aanverwant doel nastreven of wier doel van die aard is dat van die vennootschap te benaderen.
Structure & network
Ownership & control
2 board mandatesBoard mandates of this companythis company sits on their board2
1 location
1 location
Capital and shareholders
Capital over the years
- 25-02-2010 Capital stated in the act · 57,578,062.74 EUR · 6,297,570 shares
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded05-03-1999
Fiscal year end31-12
Sources
Crossroads Bank for EnterprisesNational Bank · 31 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.